Related Experiment Video
Updated: Aug 11, 2026

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
Published on: June 16, 2008
A DNA recombination-based approach to eliminate papillomavirus infection
1Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Abstract:
At present, no treatments exist that effectively target and eliminate papillomaviruses (PVs) from infected cells or prevent its replication. We are employing a strategy to prevent virus replication in PV-infected cells through the conditional expression of the herpes simplex virus type 1 thymidine kinase (TK) gene. Expression of TK in this system is expected to be triggered by a homologous recombination event between the endogenous PV genome and a nonexpressing TK gene cassette. Recombination between these two DNAs is expected to change the nonexpressing cassette into a form that expresses TK. Various constructs were generated to express the TK in the above manner. Transfection of cell lines with a TK nonexpressing plasmid did not result in TK production due to alternative splicing and polyadenylation site selection. However, cotransfection of cell lines with PV plasmids along with the above TK construct containing short segments of PV sequences resulted in a recombination event that led to TK expression as shown by Northern and Western blot analyses. We also developed a TK expression cassette utilizing an adeno-associated virus (AAV) vector. Delivery of the cassette by AAV to PV-infected cells resulted in TK expression, and ganciclovir treatment resulted in efficient killing of these cells.
Insights
This study introduces a novel strategy to combat papillomaviruses (PVs) by conditionally expressing the herpes simplex virus type 1 thymidine kinase (TK) gene. This approach, utilizing homologous recombination and adeno-associated virus (AAV) vectors, successfully eliminated PV-infected cells.
Area of Science:
- Molecular Biology
- Virology
- Gene Therapy
Background:
- Papillomaviruses (PVs) lack effective treatments for eliminating infected cells or halting replication.
- Current therapeutic strategies do not target PV replication within host cells.
Purpose of the Study:
- To develop a novel gene therapy approach for targeting and eliminating PV-infected cells.
- To investigate the conditional expression of herpes simplex virus type 1 thymidine kinase (TK) for PV treatment.
Main Methods:
- Constructing gene expression cassettes for conditional TK expression.
- Utilizing homologous recombination between PV genomes and TK gene cassettes.
- Employing adeno-associated virus (AAV) vectors for gene delivery.
- Assessing TK expression via Northern and Western blot analyses.
- Evaluating cell killing efficacy post-ganciclovir treatment.
Main Results:
- Conditional TK expression was achieved through homologous recombination in PV-infected cells.
- AAV vector delivery successfully introduced the TK expression cassette into target cells.
- Treatment of PV-infected cells with ganciclovir resulted in efficient cell elimination.
Conclusions:
- The developed strategy demonstrates a promising approach for targeting and eradicating PV-infected cells.
- Conditional TK expression, facilitated by homologous recombination and AAV vectors, offers a potential therapeutic avenue for PV infections.
Related Concept Videos
Viral Recombination
DNA Base Pairing
Homologous Recombination
Restarting Stalled Replication Forks
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

